[Federal Register Volume 61, Number 145 (Friday, July 26, 1996)]
[Notices]
[Pages 39153-39154]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-19019]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration
[DEA No. 150F]


1996 Revised Aggregate Production Quotas for Controlled 
Substances in Schedules I and II

AGENCY: Drug Enforcement Administration (DEA), Justice.

ACTION: Not of final revised aggregate production quotas for 1996.

-----------------------------------------------------------------------

SUMMARY: This notice establishes revised 1996 aggregate production 
quotas for controlled substances in Schedules I and II of the 
controlled Substances Act (CSA).

EFFECTIVE DATE: July 26, 1996.

FOR FURTHER INFORMATION CONTACT:
Howard McClain, Jr., Chief, Drug & Chemical Evaluation Section, Drug 
Enforcement Administration, Washington, D.C. 20537, Telephone: (202) 
307-7183.

SUPPLEMENTARY INFORMATION: Section 306 of the CSA (21 U.S.C. 826) 
requires the Attorney General to establish aggregate production quotas 
for controlled substances in Schedules I and II each year. This 
responsibility has been delegated to the Administrator of the DEA 
pursuant to Section 0.100 of Title 28 of the Code of Federal 
Regulations. The Administrator, in turn, has redelegated this function 
to the Deputy Administrator of the DEA pursuant to Section 0.104 of 
Title 28 of the Code of Federal Regulations.
    On May 23, 1996, a notice of the proposed revised 1996 aggregate 
production quotas for controlled substances in Schedules I and II was 
published in the Federal Register (61 FR 25895). All interested parties 
were invited to comment on or object to these proposed aggregate 
production quotas on or before June 24, 1996.
    Several companies commented that the revised 1996 aggregate 
production quotas for codeine (for sale), desoxyephedrine, 
dextropropoxyphene, diphenoxylate, dihydrocodeine, hydrocodone (for 
sale), hydromorphone, levorphanol, methylphenidate, noroxymorphone (for 
sale), opium, oxycodone (for conversion) oxymorphone and pentobarbital 
were insufficient to provide for the estimated medical, scientific, 
research and industrial needs of the United States, for export 
requirements and for the establishment and maintenance of reserve 
stocks.
    The DEA has reviewed the involved companies' 1995 year-end 
inventories, their initial 1996 manufacturing quotas, 1996 export 
requirements and their actual and projected 1996 sales. Based on this 
data, the DEA has adjusted the revised 1996 aggregate production quotas 
for desoxyephedrine, levorphanol, methylphenidate, noroxymorphone (for 
sale), and pentobarbital to meet the estimated medical, scientific, 
research and industrial needs of the United States.
    Regarding codeine (for sale), dextropropoxyphene, dihydrocodeine, 
diphenoxylate, hydrocodone (for sale), hydromorphone, opium, oxycodone 
(for conversion) and oxymorphone, the DEA has decided that no 
adjustments are necessary to meet the 1996 estimated medical, 
scientific, research and industrial needs of the United States.
    The Office of Management and Budget has determined that notices of 
aggregate production quotas are not subject to centralized review under 
Executive Order 12866. This action has been analyzed in accordance with 
the principles and criteria contained in Executive Order 12612, and it 
has been determined that this matter does not have sufficient 
Federalism implications to warrant the preparation of a Federalism 
Assessment.
    The Deputy Administrator hereby certifies that this action will 
have no significant impact upon small entities whose interests must be 
considered under the Regulatory Flexibility Act, 5 U.S.C. 601, et. seq. 
The establishment of aggregate production quotas for Schedules I and II 
controlled substances is mandated by law and by international treaty 
obligations. While aggregate production quotas are of primary 
importance to large manufacturers, their impact upon small entities is 
neither negative nor beneficial. Accordingly, the Deputy Administrator 
has determined that this action does not require a regulatory 
flexibility analysis.
    Therefore, under the authority vested in the Attorney General by 
Section 306 of the Controlled Substances Act of 1970 (21 U.S.C. 826), 
delegated to the Administrator by Section 0.100 of Title 28 of the Code 
of Federal Regulations, and redelegated to the Deputy Administrator of 
the DEA by Section 0.104 of Title 28 of the Code of Federal 
Regulations, the Deputy Administrator

[[Page 39154]]

hereby orders that the 1996 revised aggregate production quotas, 
expressed in grams of anhydrous acid or base, be established as 
follows:

------------------------------------------------------------------------
                                                             Established
                        Basic class                         revised 1996
                                                               quotas   
------------------------------------------------------------------------
Schedule I:                                                             
  Acetylmethadol..........................................             7
  Alphacetylmethadol......................................             7
  Aminorex................................................             7
  Cathinone...............................................             9
  Difenoxin...............................................        14,000
  Dihydromorphine.........................................             7
  2,5-Dimethoxyamphetamine................................    10,650,000
  Dimethylamphetamine.....................................             7
  Ethylamine analog of Phencyclidine......................             5
  N-Ethylamphetamine......................................             7
  Heroin..................................................             5
  Lysergic acid diethylamide..............................            58
  Mescaline...............................................             7
  Methaqualone............................................            17
  Methcathinone...........................................             9
  4-Methoxyamphetamine....................................            17
  4-Methylaminorex........................................             2
3,4-Methylenedioxy-                                                     
  amphetamine.............................................            17
  3,4-Methylenedioxy-N-ethylamphetamine...................            27
3,4-Methylenedioxy-                                                     
  methamphetamine.........................................            42
  3-Methylfentanyl........................................            14
  Normethadone............................................             7
  Normorphine.............................................             7
  Psilocybin..............................................             2
  Psilocyn................................................             2
  Tetrahydrocannabinols...................................        55,100
Schedule II:                                                            
  Alfentanil..............................................         8,500
  Amobarbital.............................................       301,000
  Amphetamine.............................................     2,280,000
  Cocaine.................................................       550,040
  Codeine (for sale)......................................    47,000,000
  Codeine (for conversion)................................    17,519,000
  Desoxyephedrine \1\.....................................     1,755,100
  Dextropropoxyphene......................................   118,066,000
  Dihydrocodeine..........................................       214,000
  Diphenoxylate...........................................     1,002,000
  Ecogonine (for conversion)..............................       650,100
  Ethylmorphine...........................................            12
  Fentanyl................................................       143,000
  Hydrocodone (for sale)..................................    12,145,000
  Hydrocodone (for conv)..................................     2,800,000
  Hydromorphone...........................................       718,000
  Isomethadone............................................            12
  Levo-alpha-acetylmethadol...............................       200,000
  Levorphanol.............................................        17,000
  Meperidine..............................................    10,822,000
  Methadone...............................................     4,551,000
  Methadone (for conv)....................................       364,000
  Methadone Int. (for conv)...............................     5,534,000
  Methamphetamine (for conv)..............................       723,000
  Methylphenidate.........................................    11,775,100
  Morphine (for sale).....................................    12,450,000
  Morphine (for conv).....................................    76,735,000
  Noroxymorphone (for sale)...............................        27,000
  Noroxymorphone (for conv)...............................     3,400,000
  Opium...................................................       714,000
  Oxycodone (for sale)....................................     5,571,000
  Oxycodone (for conv)....................................        37,300
  Oxymorphone.............................................        11,200
  Pentobarbital...........................................    18,000,000
  Phencyclidine...........................................            40
  Phenylacetone (for conv)................................            10
  1-Phenylcyclohexylamine.................................            10
1-Piperidinocyclo-                                                      
  hexanecarbonitrile......................................            12
  Secobarbital............................................       400,000
  Sufentanil..............................................         1,000
  Thebaine................................................     9,387,000
------------------------------------------------------------------------
\1\ 1,700,00 grams of levo-desoxyephedrine for use in a non-controlled, 
  non-prescription product and 55,100 grams for methamphetamine.        

    Dated: July 18, 1996.
Stephen H. Greene,
Deputy Administrator.
[FR Doc. 96-19019 Filed 7-25-96; 8:45 am]
BILLING CODE 4410-09-M